MiR-7, which negatively controls the function of α-synuclein mRNA (Mouradian, 2012), also serves as an anti-metastatic miRNA in gastric cancer by targeting Insulin-like Growth Factor-1 (IGF-1) (Zhao et al., 2012). The gene discussed is IGF1; the disease is gastric cancer.